Mafura a Rick Simpson (RSO) kwa Botswana: Tlhahlobo e Etlametseng ke OilWell Cannabis

Go Tlhagisisa Mafura a Rick Simpson: Go tloga kwa Nova Scotia go ya kwa Gaborone

Rick Simpson o ne a mang?

Rick Simpson e ne e se ngaka, selemo, kgološi ya dinyakišišo tsa bongaka. E ne ele morutisi wa matla go tswa kwa Amherst, Nova Scotia—mongwe yo o dirang ditiro tsa mmele yo lefoko la gagwê le tsamaile go tswa mo tlhokagalong ya botho le mokgwa wa bongaka o o mo tshwanetseng ka diphoso. Bakgwi ba Botswana ba ba tshwenyegileng ke marothodi a a sa fela, kankere, PTSD, kgotsa matshwao a a mangwe moo bongaka jwa teng bo fokotsweng, leina la Simpson le kgatlha ditlhopha tsa lefatshe. Le gakolola gore go batla thuso e e fetilwe gantsi go simolola fa bongaka jwa mokgatlho o feta maikaelelo.

O tshologilwe ka 1949, go tsena ga Simpson mo go jaaka ya cannabis e tlang morag morag kotsi ya lefatsheng la tiro ka 1997. Go tloga mo go kwadileng mo scaffolding kwa Moncton, New Brunswick e mo tshwere ka tinnitus e e sa fela, go phepa, le ditlamorago tsa post-concussion tse dikgakgamatso tsa go rwêlwê tsa bongaka di paletswego go rarolla—kgotsa di dirile gore di tshwele thata. Fa a hweditša gore cannabis e mo thusitse gomme a botsa ngaka ya gagwê go mmo tshegetša ka mokgwa oo, e ne e le moanegi. Tlholo yeo ya go tshwenyega ke ya bongaka e e tshwanegago le baBangwe ba Botswana, lebatho ba le Gaborone ka diwarateng tsa bongaka, dikliniking tsa Francistown, kgotsa dikgopolo tša bongaka tse ditoropong tsa Kalahari ka bophara.

Simpson o ithutila ka dinyakišišo tša 1974 kwa Medical College of Virginia moo THC e ne ya bonwa e feitlhetsa go kgololwa ga tumor mo dikgong. Le ge dinyakišišo tse di ne tsa se se dirwa ka dikgwedi tsa batho, di ne tsa mmila motswedi wa gagwê ka mafura a cannabis a a kgodilweng. Nakô ya bohlokwa e tšwele ka 2003 moo Simpson a bolelago gore go dirisa mafura a cannabis mo marothong a basali cell carcinoma a tharo mo letlhakoreng la gagwê a a mo diriša gore di tlogelwe magareng ga dikgwedi tse nne. Ga go na kgonthišo ya bongaka e e tswago pele—ga go na kgonthišo ya biopsy, ga go na tlhahlobo ya moragorago mo pampiring ya dikgakgamatso tsa bongaka. Le fa go le bjalo, tsebiso ya botho yeo e bile ya motheo wa tshoganyetso ya lefatshe.

Mokgwa wa Thwaelo wa RSO: Go Tlhagisisa Leeto la Grama tse 60

Molao wa maikarabelo a Simpson o be o ja mafura a a kgodilweng a cannabis a gram tse 60 mo nakong ya dikgwedi tse mmalwa go ya ka 90. Bakgwi ba Botswana ba ba nyakišišang “RSO dosing” kgotsa “how to take RSO,” mokgwa o o mowa o botlhokwa—le fa o hloke maitlamo a a maleba.

Teraiso ya Dikgato:

• Beke ya 1: Kelo ya bongolo ya moferefere (10-15mg), ka marapo a tharo letsatsi le lengwe le le lengwe
• Dibeke tse 2-5: Onnela kelo ka letsatsi la bobedi, o ya go feta gram 1 letsatsi le lengwe le le lengwe
• Dibeke tse 5-12: Dula o na le gram 1 letsatsi le lengwe le le lengwe, e aroganywa ka marapo a tharo, feletša gram tse 60 tsotlhe

Ditsela tsa Go Dirisa:

• Go Ja/Go Tshwara Tlheng: Tsela ya mathomo ya go alafa matshwao a mmele ka bophara, e tshwarwa tlheng
• Go Tshwara Mmele: Bakeng sa marotho a letlalo, e dirisiwa ka morogo
• Go Hupetswa: E dumelletšwe go rarolla tlhokagalo ya bonako e sa le molaoding wa mathomo wa keletšo

Maitlamo a Botlhokwa a Botswana:
Mokgwa wa tshwaelo o rulagantšwe go dikgopolwa tse di sa rulaganyweng tse fitlhelwang lefapheng le le sa testiweng. Fa o fihla mo kelong e e godileng, baagahi ba ja THC ya delta-9 ya go ya ka 600-900mg letsatsi le lengwe le le lengwe—dikelo tse di fetago tse di nyakišišweng kliniking. Se se na le ditlamorago tsa nnete: go tsenya maikemišetso, tshogekago, tachycardia, le tikologo ya go dirisa cannabis. Mokgwa o ne o sa kgonthwa tsekosong ya go rulaganywa, le dikgopolwa tsa semotwana di ne di fapana ka dikhutlheng tsa go dira.

Bakgwi ba ba le Botswana ba ba lekantšhago mokgwa ono, go botlhokwa go utlwa gore RSO ya tshwaelo e se bongaka jwa kajeno. Ke sephutheologolo sa histori—e bohlokwa ka tshoganyetso ya gagwê ka cannabis, e se ke e le sephirišo sa keletšo ya oncology e e tswago pele e fumanehago go dikgolo tse jaaka Princess Marina Hospital kwa Gaborone kgotsa dikgolo tsa go fetiswa kwa Afrika Borwa.

Mafura a Tshwaelo a RSO a be a Supa Eng

Dikgopolwa tsa Motlhami: Dikgopolwa tsa cannabis tse di kgolo tsa high-THC indica, tse di sa rulaganywego pakeng ga dikhutlheng tsa go dira. Bakgwi ba Botswana ba ba tshwenyegago ka cannabis, se se botlhokša bothata: letshwao la “RSO” mmarakeng wa lefelong kgotsa mo moetseng wa maragoing o ka ba le dikgopolwa tse di fapaneng kudu le tse Simpson a dirileng teng.

Sethaodi sa Go Tlosa: Simpson o dirisitše naphtha (petroleum-based lighter fluid) kgotsa 99% isopropyl alcohol—ga se go tswa go dijo. Se se na le dikotsi tse kgolo tsa sethaodi se se saletseng, e bohlokwa kudu bakeng sa setšhaba sa Botswana sa go godileng sa go dirisa mafura a cannabis a ka thegong moo ba ka se na le go testa ka lab.

Tshupetso ya Go Dira: Mokgwa o o bonolo wa bucket o akaretša dikgopolwa tsa sefofane, go thubega ka sethaodi, go filtha ka cheesecloth, le go ya ka rice cooker. Mokgwa o be rulagantšwe go nna le go fihlelelwa, ga se go nna le tshiamo.

Ponagalo: Mafura a tshweu kudu, a nene, a tshwana le tshila, le monko wa cannabis le sethaodi se se ka saletseng. Se se bapana le dikgopolo tsa kajeno tse di rulagantsweng.

Kanegelo ya Cannabinoid: 60-90% ya delta-9 THC, e fetotšwego ka moka, le cannabinoids tse nnyane ka mekgwa e e sa rulaganyweng ya tshwanelo. Ga go na kgonthišo ya lab.

Poelo ya Terpene: E bile ya lebelelwane. Sethaodi le metsi a a tshweu e ne e senyitše terpenes tse di kgonago ka pela, e bolela gore RSO ya tshwaelo e be e le ya cannabinoid fela le ge e tswa go diphatsela tse nang le terpenes.

OilWell Cannabis: Go Gologolo ga RSO kwa Houston jo j fihlelelwe ke Botswana

Kanegelo ya Rona: Go tloga kwa Ntsi e e Eletsweng go ya kwa Tshiamo ya Bongaka

OilWell Cannabis e tšweletšwe ke Colin Valencia kwa Houston, Texas—toropo e e tshwana le Gaborone, e le tshimologo ya inovašione ya bongaka le pharologano ya ditšo. Le fa leina la rona le tšwele gore le tloga boardroom. Le tšweleta Bentley, ntsi e e ne e le lelapa.

Fa Bentley a elwa maotong a a morago, baagi ba ditshepetsa ba ne ba kgothaletsa go mo bolaya. Dikgakgamatso tsa marothodi di ne tsa tshwaraganya ditlhogo tsa gagwê, ba ne ba re. E be e le kgotlano ya go fela marothoding a a tshwenyang kgotsa ka bothokwa. Le fa go le bjalo, go tloga ga e be e le kgetho.

Ka tshogekago, Colin o hweditše CBD ka potšišo yeo e fetotšeng tšhono: “O fetotše di tonnes tse kae tsa cannabis mme o sa tsebe ka CBD?” Ye e tswetšwe ke Jessica, mohlokomedi wa go thusa baagi ba ba tshwenyegago yo a bontshitšwego seo Colin—yo o tlogilego McAllen’s Borderplex region e e tshwenyang—o lebilego: cannabis e le bongaka, ga se tšebetsong fela.

Colin o thomile paste ya CBD ya botala. Bentley o tšwele mmileng, o sepela ka phapoši, o tla le bolo go bapala. Go tloga go elwa maotong go tsena go bapala. Dintsi ga di arabe go placebo—e ne e le bongaka ba cannabinoid bo kgothalletswego moo dikgakgamatso tsa bongaka di paletswego.

Bentley o tshela dikgwedi tse leshome tše, a hwa ka tshologo ya matshelo a gagwê a le fase ka 20. Mo dikgweding tseo, Colin o thomile dipalo tse di maleba tša mafura tše nne tša kgološo: neurodegeneration (CBG neuroprotection, THCa PPARγ agonism), dementia (CBC neurogenesis), glaucoma (THC CB1 agonism), le arthritis (multi-pathway anti-inflammatory synergy).

Cannabinoid e le nngwe le nngwe e ne e sa lekane. Matshwao a a fetogago a Bentley a nyakega dipalo tse di maleba tsa cannabinoids tse dintsi. Tlhokagalo ye e dirileng Colin go nna morutisi wa software yo o rulagantsweng, a dira tshupetso e le nngwe le nngwe bakeng sa Baylor College of Medicine—go tlogela tsebo e e tseneletšeng ya cannabis le cannabinoids go tloga go tshiamo ya tekhniki ya bongaka.

Tsholofelo ya Rona: Melao e Meraré Bakeng sa Botswana

1. Go Fihlelelwa go kwa Godimo ga Go Tlala
Ga go kgakelwe karolo ya bongaka. Motho yo mongwe le yo mongwe wa dilemo tša 21+ o ka reka. Re romela mafura ka lefatshe lohle la United States le ka ntle go Botswana le ditshaba tse dingwe moo diprodakeng tsa rona tsa hemp tsa mmelaelo di lego legale. Rick Simpson a dumela gore bongaka bo swanetše go fihlelelwa ke motho mongwe le mongwe; re thomile sephirišo le mokgwa wa go arolelana seo se dira seo se lekalekane le molao.

2. Bogolong jo bo Laolwa ke Motlhomi
Formola ya rona e akaretsa THCa ya 1,500mg ka mofuta wa gagwê wa acidic, wa go sa tsenya maikemišetse. O laola gore o e dirise e le e sa tshwengwa bakeng sa go ntsha go tshwenya mo metseng ye sa senya maikemišetse, kgotsa o e fetole gae go e nna delta-9 THC ya go ya ka 1,315mg bakeng sa bogolong bjo bo tsenya maikemišetse ka moka. Bakeng sa BaBotswana bao ba hlokago go tšea ditiro, go feta, kgotsa go busa bana mo metseng, taolo ye ke ya phelopele.

3. Tlhomamiso e e Buang ka Moka
Re tšweletša dipalo tsa rona ka moka morago ga kgwebo—cannabinoid e le nngwe le nngwe, gram e le nngwe le nngwe—gore motho yo mongwe le yo mongwe yo o sa kgonego go reka diprodakeng tsa rona a ka hwetsa dikgopolwa le go dira sengwe sa gago. Se se bontšha tshoganyetso ya Simpson ya go arolelana ka mahala bakeng sa nako ya kajeno.

4. Go Tsweletswa ke Diakanyo, Ga se Go Tlhomamisa
Karolo ya GENERAL KNOWLEDGE ya rona (e akaretswago ka fa tlase) e bontšha marapo a rona a go ithuta e le nnete ka seo selemo se re sego ka nnete. Re aroganya pakeng ga dikgakgamatso tse di tshegetšweng ka moka, dinyakišišo tse e lego gore di tla kgona, le go tlhomamisa ka go feta—ka ge BaBotswana ba swanetše go hwetsa nnete, ga se go hype.

Go Lekana le Molao wa Farm Bill le Sefoka sa Molao Bakeng sa Botswana

RSO Sublingual Oil ya rona e akaretsa delta-9 THC fela ya 90mg mo boteleng ya 30mL ka moka—3mg kwa mL ngwagong—e le ka fatshe ga tekanyo ya 0.3%. Se se dira gore e le legale ka molao wa U.S. federal le gore e ka romelwa ka ntle.

Bakeng sa Bareki ba Botswana:
THCa ke motšhiri wa acidic, wa go sa tsenya maikemišetse go tloga go delta-9 THC. E lemogwa ke Farm Bill ka nako ya thekiso ka ge e sa fetotšege. Fa o e fetsa ka 260°F (125°C) dikotara tša 45-60, e fetosa go e nna delta-9 THC (1mg THCa → 0.877mg delta-9 THC). Se se bolela gore prodaketšana e le nngwe le e le nngwe ya molao e ka šoma e le go sa tsenya maikemišetse go ntsha go tshwenya kgotsa bongaka bjo bo tsenya maikemišetse ka moka—ka moka go ya ka go o laetše morago ga go reka.

Tsebiso e Bohlokwa ya Molao: Bareki ba na le karolo ya go tlwaela le go lekana le melao ya Botswana mabapi le diprodakeng tsa hemp. Re fa ditokomane ka moka, Diakanyo tša Dithahlobo, le dipesente bakeng sa ditlhokomedi tsa go tswa ka ntle. Sefoka sa molao sa Botswana sa kajeno sa diprodakeng tsa cannabis se swanetše go kgonthwa ka leina la gago. Ge THCa kgotsa cannabinoids tse di tswago go hemp di laelwa mo Botswana, bareki ba amogela molaodi ka moka wa ditlhokomedi le molao.

Dipalo ka Moka tsa Prodakeng ya Rona: Tlhomamiso seo o kgona go se Kgontha

RSO Sublingual Oil – $129.99

Cannabinoid	Palomoka
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Ka moka	16,590mg

• Mofuta: Botelo ya 30mL (553mg ya cannabinoids tse di šitšwang kwa mL)
• Terpenes tse di Tshegago: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
  | Motsamaisi: MCT oil ya organic
  | Go simolola: 15-45 metsotso (sublingual)
  | Nako: 4-6 diiri
  | Bioavailability: 13-19%
  | Go duela: Graduated dropper ka increments ya 0.1mL
  | Dikgopolo: 40-60 dikelo kwa boteleng

RSO Vape Cartridge – $49.99

Cannabinoid	Karolana
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%
Terpenes tse di Tshegago	5%+

• Mofuta: Karetisi ya gram 1 ya 510-thread
  | Go simolola: 1-2 metsotso (go isa ka pela)
  | Nako: 2-4 diiri
  | Bioavailability: 10-35%
  | THCa e fetogela delta-9 THC automatikadi ka metseng ya vape (400-450°F)

Mokgwa wa Bareki ba Botswana go Fihlela Diprodukeng tša Rona

Bakeng sa BaBotswana ba le Ditirong (USA):
Re fana ka go romela mahareng ga letsatsi le le le la Houston le go romela lefatshe lohle la Amerika. Ge o le mopedi wa Botswana, motho wa bašomi, kgotsa mongwaere wa U.S., diprodakeng tša rona di ka go fihlela ka dikgwedi.

Bakeng sa Bareki kwa Botswana:
Re romela mafura ka ntle le ditokomane ka moka. Pekese ngwagong e akaretsa:

• Diakanyo tša Dithahlobo (COAs) bakeng sa cannabinoid e le nngwe le e le nngwe
  | Dipesente tse di maleba tsa prodakeng
  | Ditokomane tsa go lekana le Farm Bill
  | Letshwao le le lokilwego go ditlhokomedi

Dikakanyo tša Go Romela kwa Botswana:

• Go fihlela go tšwa go 7-21 diiri tša tšhaba ka go dirisa USPS International
  | Bareki ba na le karolo ya go lefa ditlhokomedi kgotsa ditefello tsa go tswa ka ntle
  | Melao ya Botswana ya go tsea mafura a hemp ka ntle e swanetše go kgonthwa le maikulthe
  | Ga re kgone go bontshwa gore ditlhokomedi tša Botswana di tla amogela diprodakeng—bareki ba amogela molaodi ono
  | Pekese e le yona e se e bonagale, ga go na letshwao la cannabis le le bonagalago

Kopanya Bakeng sa Ditaelo tse di Tswago Kwa Ntle:
Mohala: +1 (832) 416-2816
Imeile: [email protected]
Wepsaete: https://oilwellcbd.com/

Karolo ya Go Dirisa Prodakeng go ya ka Matshwao a Botswana

Tsebiso e Bohlokwa: Dika tša go dirisa tse di tsweletšwego ke diakanyo tša go tšwa go dipalo tsa cannabinoid tse di tsweletšweng karolong ya GENERAL KNOWLEDGE ya rona. Ga se dikgakgamatšo tsa bongaka, ga se tse di dumeletšweng ke FDA, le ga se sephirišo sa keletšo ya bongaka ya batsamaisi. Dikgopolo tša go maleba di swanetše go bapatswa le motsamaisi wa bongaka pele o diriša diprodakeng tsa cannabinoid. Diprodukeng tša rona ga se di lekodiswê ke FDA le gore ga se dire mabaka a go hlahloba, go alafa, go pholola, kgotsa go thibela papadi.

Bakeng sa Tšegetšo ya Kankere (Ditlamorago tsa Khemotherapi):

• Pele ga keletšo: 0.5-1.0mL sublingual ka ira 1 pele ga khemotherapi
  | Go tshwenya ka pela: 2-3 puffs tsa vape bakeng sa go rarolla bonako
  | Morago ga keletšo: 0.5mL ka diiri tse 6 go ya ka go hloka
  | Tšegetšo ya botshelo: 1.0-2.0mL pele ga go robala (e fa 25-50mg CBN)
  | Diakanyo: Dikgakgamatšo tša antiemetic tša delta-8, delta-9 bakeng sa go tshwenya go tswa go khemotherapi, CBD bakeng sa go fokotsa tshogekago

Bakeng sa Marothodi a a Sa Fela (Arthritis, Fibromyalgia, Neuropathy):

• Metseng: 0.3-0.5mL sublingual e sa fetotšwego (go sa tsenya maikemišetse go ntsha go tshwenya)
  | Bosigo: 0.5-1.0mL sublingual e fetotšwego (go rarolla marothodi le tšegetšo ya botshelo)
  | Go tshwenya ka pela: Vape go ya ka go hloka go isa ka pela
  | Diakanyo: Go kopanywa ga go ntsha go tshwenya ga cannabinoids tse dintsi go tswa go CB2, COX-2, le mekgwa ya PPARγ

Bakeng sa Matshwao a Botshelo:

• Pele ga go robala: 1.0-2.0mL sublingual
  | Ka 2.0mL: E fa 50mg CBN (kelo mo dinyakišišong tša botshelo tša 2024)
  | Ka 1.0mL: E fa 25mg CBN (ka godimo ga tekanyo ya go fokotsa go tshwenya)
  | Diakanyo: Karolo ya CBN go tšwela pele go botshelo e e tšwetšwego pele

Bakeng sa Tshogekago le PTSD:

• Go ntsha tshogekago mo metseng: 0.3mL sublingual e sa fetotšwego (CBD + CBG le go sa senyege)
  | Bosigo: 1.0mL sublingual (kanegelo ya moka le CBN bakeng sa botshelo)
  | Diakanyo: Dikgakgamatšo tša anxiolytic tša CBD, pharmacology ya CBG, go fetola ya limonene entourage

Kanegelo ya Terpene: Bongaka jo Bo Nkgafetseng

Diprodukeng tse di lebeletšwe di akaretsa terpenes tše tharo tše di lekanego ka tekanyo ya 5%:

• Limonene: Monko wa citrus-bright, dikgakgamatšo tša go tšweletša moya
• Myrcene: E e tshwana le lefatshe, e rile (e tshwanela le ditlhare tša bongaka tša Setswana)
• Caryophyllene: Pepper/spice, agonist ya CB2 bakeng sa go ntsha go tshwenya
• Pinene: Forest-fresh, e tšweletša boitsebiso
• Linalool: Floral (lavender), e rile
• Humulene: Earthy/woody, go ntsha go tshwenya
• Terpinolene: Piney/fruity, dikgakgamatšo tse di komonago

Bakeng sa BaBotswana bao ba tsebego ka ditlare tša bongaka tša tshwanelo jaaka motsaodi (wormwood) kgotsa lerotholi (aloe), go tlhalogela terpenes e kgokaganya selemo sa cannabis le tsebo ya ditlhwatlhwa. Dikgopolwa tse di nkgafetseng ke sefapano sa go tloga go bongaka jwa tshwanelo go ya go bongaka jwa cannabinoid ya kajeno.

TSEBO YA KAKARETSO: Selemo Mo Dikgopolang Tse Ohlilego

Mokgwa wa Dinyakišišo le Go Beakanya Diakanyo

Go kgetha ga rona ga diakanyo go beakanya: diteko tsa makgoa a batho → ditlhomamiso tse di rulagantsweng → ditlaleletšo tsa dikgolo (NIH/NCCIH) → dinyakišišo tsa pele ga kliniki/tsa mokgwa. Se se botlhokwa ka ge sefoka sa diakanyo ga se lekane. CBD le delta-9 THC ba na le ditaba tša batho tse di matlafaditšwego; delta-8 THC, THCa, CBG, CBN, CBC, le terpenes di tšeela go feta go tswa go ditlhomamiso le dinyakišišo tsa diphoofolo [1]-[29].

Mothopo wa Dikgolo: Seo se Revišo ke NIH

National Center for Complementary and Integrative Health (NCCIH) e bontšha diakanyo tse di matlafaditšwego tša cannabinoid bakeng sa:

• Epilepsies tse itsego (CBD)
• Go tshwenya/go hemiwa go tswa go khemotherapi (THC)
• Go fokotsa kgahlego/mafhungo go tswa go HIV/AIDS (THC)

Bakeng sa tšhomo, diakanyo di bonolo kgotsa e le gore di sa tswele pele. FDA e se e dumeletše sefofane sa cannabis ka bophara bakeng sa tšhomo ya bongaka. Dikgopolo tsa tshiamo di akaretsa go senyegega, tikologo ya go dirisa cannabis, dikotsi tsa bolebana, go tloga mafatsheng, le go se lekane ga letshwao [1].

Dipalo tša Diakanyo tša Cannabinoid

CBD (Cannabidiol)

Diakanyo tse Dikgolo: Matshwao a go hema (Epidiolex) [1][2]
Tshogekago: Ditlhomamiso tša 2024 di bontšha tshwayotshwayo ya go fokotsa tshogekago le ge ditapolo tša kliniki di bonolo [3]
Marothodi: Ponelopele ya 2024 e bona diakanyo tse di tšweletšago le ge di sa lekanne [4]
Botshelo: Ponelopele ya 2023 e laetsa dinyakišišo tse di bonolo ka gare [5]
Tshiamo: Ditlhomamiso tša 2023 di laetsa dikotsi tša go gola ga di enzymes tsa mala, kudu ge go na le polypharmacy [6]
Tshwantsho ya Tatelano: Cannabinoid e le nngwe le e le nngwe e e sa tsenya maikemišetse e e nang le diakanyo tse di matlafaditšwego, le ge diakanyo tse di matlafago di tsepametšwe mo dikarolong tse itsego

CBG (Cannabigerol)

Diakanyo: Ditlhomamiso le tsa pele ga kliniki fela; ditaba tsa batho di bonolo [7][8]
Pharmacology: E šoma mo mabakeng a cannabinoid, alpha-2 adrenoceptors, mekgwa ya 5-HT1A [7]
Phonelo: Matshwao a monagano, inflammatory bowel disease, kgatlhogolo ya go tshwenya
Tshogekago: E rekwa ka lefapheng le ge diakanyo di bonolo [7]
Tshwantsho ya Tatelano: Cannabinoid e e tšweletšego, go sa kgonthwa kudu kliniking

Delta-8 THC

Diakanyo: E na le bohlokwa ba pharmacology e le gore e sa lebelelwe kudu kliniking go feta delta-9 [9]-[11]
Pharmacology: Agonist ya CB1 e e bonolo, ga e na maatla a delta-9 [9]
Bogla le Batho: Ponelopele ya 2023 e laetsa ditaba tša ditlamorago, dikgopolo tsa boleng bja go dirisa [10]
Tshwantsho ya Tatelano: Analogue ya THC e e tsenyago maikemišetse le data ya tshiamo e e sa feletšego

THCa (Tetrahydrocannabinolic Acid)

Diakanyo: E bohlokwa ka tšhemikale le go sa na le diakanyo tša tšhomo tsa batho [12]
Phapano e Bohlokwa: Ga e tsenye maikemišetse le ge e sa fetolwa go e nna THC [12]
Dinyakišišo: Dinyakišišo tsa in vitro/dikgwele di laetsa phonelo ya go ntsha go tshwenya, go sireletša monagano, le go fokotsa go hola ga matšhila [12]
Tshwantsho ya Tatelano: Molekule wa motšhirio seo go tshwela pele ga go se lebelela go ya ka go dirisa le go boloka

Delta-9 THC

Diakanyo: Tse di matlafago tsa cannabinoids tseo di tsenyago maikemišetse, ditlamorago tša nnete di bonala thata [1][13]-[15]
Diakanyo tse Dikgolo: Go tshwenya/go hemiwa go tswa go khemotherapi, go fokotsa kgahlego/mafhungo go tswa go HIV/AIDS, ditlamorago tse dingwe tša MS/marothodi [1]
Marothodi: Ponelopele ya 2022 e bona phaelo ya bonako le go oketša go phepa, go rile, go tshwenya [13]
Bogla le Mowa: Ponelopele ya 2025 e kgatha le THC e kgolo go tshwenya, go bina, le tikologo ya go dirisa cannabis [15]
Tshiamo: Tshogekago/go tšhoganêga mo dikelong tse kgolo, tachycardia, go lebana, dikotsi tsa bolebana [1][14][15]
Tshwantsho ya Tatelano: Bohlokwa bja tšhomo e le nnete le ge go na le dikotsi tse di kgolo

CBN (Cannabinol)

Diakanyo: Diakanyo tsa batho di bonolo; go tlhomamisa go feta diakanyo [12][16][17]
Dikgopolo tsa Botshelo: Ponelopele ya 2021 e hweditše GA se diteko tsa kliniki tseo di dirago mekgwa ya botshelo yeo e kgonthwago [16]
Fetotšo ya 2024: Dinyakišišo tša botshelo tsa cannabis di sa lekane le mokgwa wa go dirisa lefapheng [17]
Tshwantsho ya Tatelano: Leina la tšhono le matlafaditšwego go feta sefoka sa kliniki

CBC (Cannabichromene)

Diakanyo: E tšweletša, e kgatlha, e fetile go feta go tšwa go dinyakišišo tsa pele ga kliniki [18][19]
Pharmacology: E fapana le cannabinoids tse dingwe; phonelo ya go fokotsa go utlwisa boloko, go tshwenya, go tšhwenya epilepsy [18]
Tshiamo: Diprodukeng tsa OTC di rekwa le ge ga go na diakanyo/tshiamo [18]
Tshwantsho ya Tatelano: Target ya dinyakišišo tse di tshegetšwego, ga se tšhomo e e kgonthwago

Dipalo tša Diakanyo tša Terpene

Limonene

Diakanyo: Ditlhomamiso le tsa pele ga kliniki; tshiamo ya ditaba tša oxidation products e le allergens [20]-[22]
| Activity: Antioxidant, go ntsha go tshwenya, go sireletša pelo, go sireletša mala [21]
Tshwantsho ya Tatelano: E šoma biologically le ge diakanyo tša cannabis tse diragetšwego di nyaka tšegetšo ya batho

Myrcene

Diakanyo: Go feta go tšwa go dinyakišišo tsa pele ga kliniki; diakanyo tsa batho di bonolo kudu [20][23]
Tshogekago ya Kgakgamatšo: Kgakgamatšo ya “terpene ya go rilego” e matlafaditšwego go feta diakanyo [23]
Tshwantsho ya Tatelano: Bioactive e e tšweletšego, dikgopolo tse di tshwanelago di le bonolo

Caryophyllene

Diakanyo: E kgatlha go feta ka mokgwa—agonist ya CB2 e e kgethegileng [24]
| Activity: Go ntsha go tshwenya, go fetola immune system, go sireletša monagano, go sireletša mala [24]
Tshwantsho ya Tatelano: Candate e e matlafago go feta bakeng sa bohlokwa bja cannabinoid system, le ge e sa lebelelwe kliniking

Pinene

Diakanyo: E tšweletša mo go tšwa go dinyakišišo tsa pele ga kliniki, go kgonthwa kudu kliniking [20][25]
Tshogekago: Dikgopolo tša go lemoga/go tšweletša moya di dumeletšwe, ga se nnete [25]
Tshwantsho ya Tatelano: E nyaka tatelano, dikgopolo tsa cognition di dinyakišišo

Linalool

Diakanyo: Tatelano e kgolo ya go tšwa go dinyakišišo tsa pele ga kliniki, go kgonthwa kudu kliniking [20][22][25][26]
| Activity: Tshogekago, moya, pharmacology ya bokgoni bja monagano [25][26]
Tshiamo: Linalool hydroperoxides tseo di fetotšwego ke allergens [22]
Tshwantsho ya Tatelano: Bioactive e e tshegetšwego, dikgopolo tsa tšhomo di le bonolo

Humulene

Diakanyo: E kgatlha go feta, le ge e le gore e sa tswele pele [20][27]
| Activity: Go ntsha go tshwenya, dikgopolo tse dingwe tsa cannabimimetic mo diphoofolong [27]
Tshwantsho ya Tatelano: Target ya dinyakišišo tse di kgatlhago, e se ya felo kliniking

Terpinolene

Diakanyo: E itsego kudu kliniki mo lenaneng le [20][28]
Pono: E tšweleditšwe ke dinyakišišo tsa in silico, in vitro, diphoofolo [28]
Tshwantsho ya Tatelano: Biologically e kgatlha, kudu e sa lebelelwe kliniking

Dikgopolo tša Kgatelelo le Dipoelo tša Botswana

Melao e meraré ye e bohlokwa:

1. Diakanyo ga di lekane—CBD le delta-9 THC ba na le ditaba tša batho tse di maleba; tseo dingwe di hloke tshogekago [1]-[29]
2. Dikopolo tsa mafura/molecule/synthetic/terpene ga di swane—phošo e e tshwanegago mo go ngwadaganyišwago ka cannabis
3. Cannabinoids tse nnyane di ka tshwanela ka go di sa lebelela—diakanyo di kgola kudu
4. Boleng bja prodakeng bo le bohlokwa bjalo ka mohuta wa molekule—go se lekane ga letshwao, go tloga mafatsheng, go dira go feta go ama diponagalo tsa lefapheng [1][10][11][14]
5. Tšhemikale ya THCa e fetoga go ya ka go boloka/metsi—go fetola cannabinoids tse di acidic go e nna THC e e tsenyago maikemišetse e fetola karolo ya go tloga [12]

Dikgopolo tse Difsa tse go Tlhomamisa thata

Go Tlhomamisa thata	Go Nepa More
CBN ke thušo ya botshelo e e kgonthwago	Diakanyo tša botshelo tša CBN di sa matlafale kudu le go se na teko e e matlafago [16][17]
Myrcene e thusa go rilega ka nnete	Diakanyo tša batho bakeng sa go rilega di bonolo kudu [23]
Terpenes di na le go kgonthwa ga entourage	Dikgopolo tsa entourage di kgatlha le ge diakanyo tsa kliniki di bonolo [20][29]
THCa e ya gape ga se e tsenye maikemišetse	Metsi e fetola THCa go e nna THC e e tsenyago maikemišetse [12]
Delta-8 e safe ka ge e tšwa go hemp	Delta-8 e tsenyago maikemišetse le data ya tshiamo e e sa feletšego [9]-[11]

Dipoelo tša Botlhokwa Bakeng sa Bareki ba Botswana

• CBD le delta-9 THC ba na le diakanyo tse di matlafaditšwego tsa batho
• Delta-8 THC ga e tshabe—e tsenyago maikemišetse le data ya tshiamo e e bonolo go feta ya delta-9
• THCa e fetola go ya ka go dirisa—mofuta wa raw vs. wa fetsa o fapana thata
• CBG, CBN, CBC di tšweletša tsa selemo le go sa lebelelwe kudu kliniking
• Dikgopolo tša terpene di swanetše go ba le tshogekago le go lebana, e le tšweletšwego ke diakanyo tša batho moo e lego gona

TSHWAYOTSHWAYO YA MEDIA: Lefoko la Rona la Go Tlhomamisa

ABC13 Houston: Ditshwantsho tše Tharo, Dikgwedi tše Supa, Lefoko le Le Le Tshwanegilego

Magareng ga Phato 2019 le Moranang 2023, ABC13 (KTRK)—sephutheologo sa ABC sa Houston seo e mopedišang toropo e kgolo ya America ka boraro—se tlhatlhetše Colin Valencia le OilWell Cannabis ka ditshwantsho tše tharo tše di fapanego. Ba reledi ba ba mmalwa ba supa dikgopolo tša rona go tloga go tšhomo, molao, bongaka, bokgoni bja setšhaba, le dipolitiki. Ga go na moagi wa cannabis wa Houston yo a nago le lefoko le lefe le media.

Seo se Bohlokwa Bakeng sa Botswana:
Ge o lekantšha go reka RSO go tswa go tekanyong ya kilometa tse dikgolo tšweu, o nyaka kgonthišo gore re le nnete, re tshegetšwe, le gore re le bobebe ka moka. Lefoko la rona la ABC13 le fana ka kgonthišo yeo ya go tswa pele—seo se se kgonnego ke makala a a sa kgonego go rulaganywa.

Teraiso ya Ditshwantsho: Leeto la Rona la Media

Phato 15, 2019: “Texas CBD businesses booming”
Moleledi: Tom Abrahams
Kgopolo ya rona ya mathomo: “Ga ke leka go rekela batho snake oil. Ga ke leka go rekela batho tshogelo, le ge go na le dinyakišišo tse dintsi tseo batho ba swanetšego go di tseba le leka le gore e le mofuta wa gabotse go di fa sekolo sa go kgona go ba dira seo se tla ba nepagale kgotsa go ba se dira.”

Tsebiso ye—e feletšwego mo TV e le yona e le yona pele batho ba bantši ba Amerika ba tsebe ka CBD—e beakanya marapo a rona a go ruta ka nnete seo se tšwelela le kajeno.

Mopitlwana 22, 2021: “Entrepreneur creates direct-to-consumer business”
Moleledi: Tom Abrahams
E tlhatlhetše karolo ya rona go thusa baagi ba ba bangwe jaaka Jonathan Pina go thoma dikgwebo tsa cannabis tsa molao. Colin a re: “Marothodi a a tšwa ka mekgwa ye mentši.”

Mopitlwana 24, 2021: “What is Delta 8 THC”
Moleledi: Steve Campion
Poledišano ya seswantšho:

• Campion: “Ke ka lebaka la eng motho a ka nyaka go hupetswa se?”
• Colin: “Ga nkušê gore go se nepagale go re o tla tsenywa maikemišetse. Mohlomongwe o nyaka go tsenywa maikemišetse.”

Tshogekago ye e kgahlago—e bolokilwego e se e sensore ka ABC—e bontšha marapo a rona a go bolela nnete, le ge go le bothata.

Phatwe 20, 2021: “Houston CBD shop giving away free products for COVID vaccine”
Re faeletswe makgona a a kgethegileng a caviar a 1,000 (go ya ka $35,000 ya prodakeng) go kgothaletsa go fapana le COVID-19. Re rulagane le Toropo ya Houston, le go se na morero wa dipolitiki: “Re nyaka fela gore Houston e nne e le botlhokwa ka moka.”

Mosegamanye 19, 2021: “Texas ban over Delta 8”
Ge Texas DSHS e fetotše Delta-8 go e nna Schedule I ka bosigo, re tlogetše diprodakeng tše di feletše pele go tšwa molao le re leletše baagi ba ba bangwe bao ba sa tsebago gore ba romela dilo tsa molao. Tshoganyetso ye ya go tshwanela mo lefaseng la kgatelelo e laolwa ke sebopegi sa rona.

Mosegamanye 7, 2022: “Biden marijuana pardon”
Tlhahlobo ye e bontšhitše histori ya go fetogwa ga Colin le cannabis: “O tshwenyegwa ka ditiro, dikgopolo, le banking, ke re ka tšohle. Ke beela matsapa gore batho ba se sa swerwe ka se.”

Bakgwi ba Botswana, se se kgonthiša gore ga re ba ba tšhomo ba dikgwebo—re tshela ditlamorago tša thibelo le re thomile kgwebo ya molao le tshiamo.

Moranang 21, 2023: “Marijuana industry getting creative”
Sengwalwa sa “Renaissance” sa Colin: “Jaaka gona ke nako e—jaaka Renaissance—e bohlokwa e le gore e bapajwe jaaka gona.”

Seo se Fetago: Seo Ditshwantsho tše Tharo se Bolelago

Go Tšweletsa: Re tlhatlhetšwe mebokong ye meraro ya go fokologa diokelo tša tšhomo—boom ya CBD, go tšweletša ga Delta-8, kgateleto ya COVID, go fetola ga molao, go tlogela ga mopresident. ABC13 e tšwetše go rena ka lebaka la melaetsa ya rona ya go tšweletsa.

Boterata: Tšhomo, molao, bongaka, bokgoni bja setšhaba, dipolitiki—ga go na mongwe wa Houston yo a fetotšwego se fapa.

Tiragatso ya Setšhaba: $35,000 ya prodakeng ka mahala bakeng sa bogla le batho, tshoganyetso ya go tshwanela mo kgatelelong ya molao, go thusa baagi ba ba bangwe—ke maitlamo a a kgonthwago, ga se dikgopolo tsa go rekisa.

Dikgetho tša Botho: Histori ya go fetogwa ga Colin e dira tše nngwe le tše nngwe di kgolo thata. Se ke kgothaletšo go tswa mo go tshwenyegang ka nnete.

Go Šuthiša: Go tloga go “moagi wa wholesale” (2019) go ya go kgahli ya tšhomo (2023), go gola ga rona go tšwela le legal cannabis.

Lefoko le la media ga le rekiwe—le hweditšwe fela. Bakgwi ba Botswana ba ba lekantšhago go tshepa kgwebo e lego tekanyong ya kilometa tse dikgolo tšweu, ke kgonthišo ya gago.

Dikgopolo tša Mafelelo: Marapo a Rona a Botswana

Rick Simpson o thomile tshoganyetso ka go arolelana mafura le go ruta batho go a dira. O šomile mo nakong ya thibelo moo baagi ba ba na le kankere ba swanetšwego go kgetha pakeng ga bongaka bja molao kgotsa ga go bongaka.

Jaaka gona, sefoka se a fapana. Kwa Botswana le lefatsheng ka bophara, baagi ba na le dikgetho—le go feta seo, ba na le tsebo e kgolo, e ntši ya go se nnete. Tshega ya rona ke go fana ka seo Simpson a se kgonego: dipalo tsa RSO tse di rulagantsweng, tse di testiwago, tse di lekanego le molao le di tshegetšwe ke selemo se se bulego.

Le ge o le Gaborone goba Maun, Francistown goba Kasane, o tshwenyegilego le kankere, marothodi a a sa fela, PTSD, kgotsa o nyaka go tseba cannabinoids ka botlalo, o na le tokelo ya go ithuta ka nnete. Ga se snake oil. Ga se tshogelo ya go se nnete. Fela tsebo e e kaone ka moka, gore o ka go fa sekolo se se kaone le go kgetha ge se se na le go wena kgotsa se se go se dira.

Dipalo tša rona di tšweletšwe. Diakanyo tša rona di laeditšwe. Lefoko la rona la media le bonagala. Kanegelo ya mogape wa rona ke ya botho. Le marapo a rona a tshiamo ga a fele.

Na o hloka RSO? Ikopanye le rona ka +1 (832) 416-2816 kgotsa [email protected]. Re le gona go arabela dipotšišo tša gago—le ge o le Houston goba Gaborone, le ge o lokile go reka kgotsa o nyaka tsebo e nngwe.

Sehlogo se ngwadilwe bakeng sa mekgwa ya go ithuta. Diprodukeng e akaretsa go feta 0.3% ya delta-9 THC le di lekana le Farm Bill. Bareki ba na le karolo ya go kgonthiša legale mo Botswana. Dikgakgamatšo tše di sa lekodiswê ke FDA. Diprodukeng ga se dire mabaka a go hlahloba, go alafa, go pholola, kgotsa go thibela papadi. Dikgopolo tša go maleba di swanetše go bapatswa le motsamaisi wa bongaka pele o diriša.

ENGLISH

Rick Simpson Oil (RSO) in Botswana: The Complete Guide by OilWell Cannabis

Understanding Rick Simpson Oil: From Nova Scotia to Gaborone

Who Was Rick Simpson?

Rick Simpson wasn’t a doctor, scientist, or medical researcher. He was a power engineer from Amherst, Nova Scotia—a blue-collar tradesman whose journey into cannabis advocacy began with personal suffering and a medical system that left him without answers. For residents of Botswana dealing with chronic pain, cancer, PTSD, or other conditions where conventional medicine has fallen short, Simpson’s story resonates across continents. It reminds us that the search for relief often begins when institutional medicine reaches its limits.

Born in 1949, Simpson’s introduction to cannabis came after a workplace injury in 1997. A scaffolding fall in Moncton, New Brunswick left him with persistent tinnitus, dizziness, and post-concussion symptoms that prescription medications failed to resolve—or made worse. When he discovered cannabis provided relief and asked his doctor to support this approach, he was refused. This experience of medical dismissal is one many Batswana know intimately, whether in Gaborone’s medical wards, Francistown’s clinics, or rural health posts across the Kalahari.

Simpson learned about a 1974 study at the Medical College of Virginia where THC reportedly slowed tumor growth in mice. While this research was never replicated in human trials, it sparked his curiosity about concentrated cannabis oil. The pivotal moment came in 2003 when Simpson claimed that applying cannabis oil to three basal cell carcinoma lesions on his arm caused them to disappear within four days. No independent medical verification exists—no biopsy confirmation, no clinical follow-up in peer-reviewed literature. Yet this personal testimony became the foundation of a global movement.

The Traditional RSO Protocol: Understanding the 60-Gram Journey

Simpson’s core recommendation was consuming 60 grams of concentrated cannabis oil over approximately 90 days. For anyone in Botswana researching “RSO dosing” or “how to take RSO,” this protocol is essential knowledge—though it requires critical context.

The Titration Schedule:

• Week 1: A dose the size of half a grain of rice (10-15mg), three times daily
• Weeks 2-5: Double the dose every four days, building toward 1 gram per day
• Weeks 5-12: Maintain 1 gram daily, divided into three doses, until all 60 grams are consumed

Administration Methods:

• Oral/Sublingual: Primary route for systemic conditions, placed under the tongue
• Topical: For skin lesions, applied directly with bandages
• Inhalation: Acknowledged for immediate symptom relief but not as primary treatment

Critical Context for Botswana:
The traditional protocol was designed around crude, unstandardized material with no lab testing. At peak dosing, patients consumed roughly 600-900mg of delta-9 THC daily—doses far exceeding anything studied clinically. This carries real risks: severe intoxication, anxiety, tachycardia, and cannabis use disorder. The protocol was never validated in controlled trials, and the starting material varied by batch.

For Batswana considering this approach, it’s crucial to understand that traditional RSO is not modern medicine. It’s a historical artifact—important for its role in cannabis advocacy, but not a substitute for evidence-based oncology care available at institutions like Princess Marina Hospital in Gaborone or referral centers in South Africa.

What Traditional RSO Actually Was

Source Material: Single high-THC indica strains, with no standardization between batches. For Botswana’s cannabis-curious consumers, this highlights a key problem: the “RSO” label at a local market or online seller may contain wildly different compounds than what Simpson originally made.

Extraction Solvent: Simpson used naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol—neither food-grade. This poses significant residual solvent risks, especially concerning for Botswana’s growing community of DIY cannabis extract makers who might not have access to lab testing.

Production Process: A simple bucket method involving plant material, solvent agitation, filtration through cheesecloth, and evaporation in a rice cooker. The process was designed for accessibility, not safety.

Appearance: Nearly black, thick, tar-like oil with a strong cannabis and possible solvent-residual odor. This contrasts sharply with modern formulated products.

Cannabinoid Profile: 60-90% delta-9 THC, fully decarboxylated, with minor cannabinoids at uncontrolled natural ratios. No lab verification.

Terpene Content: Effectively zero. The solvent and heat process destroyed volatile terpenes, meaning traditional RSO was cannabinoid-only despite coming from terpene-rich plants.

OilWell Cannabis: Houston’s RSO Evolution Now Available to Botswana

Our Origin Story: From a Paralyzed Dog to Medical Precision

OilWell Cannabis was founded by Colin Valencia in Houston, Texas—a city that, like Gaborone, is a hub of medical innovation and cultural diversity. But our story doesn’t begin in a boardroom. It begins with Bentley, a dog who was family.

When Bentley became paralyzed in his back legs, veterinarians recommended euthanasia. The pain medications would destroy his organs, they said. It was either a painful, prolonged decline or immediate mercy. But giving up wasn’t an option.

In desperation, Colin discovered CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” This came from Jessica, a rescue worker who saw what Colin—who had grown up in McAllen’s dangerous Borderplex region—had missed: cannabis as medicine, not just recreation.

Colin created a CBD golden paste. Bentley got up, walked across the room, and brought his ball to play. From paralyzed to playing fetch. Dogs don’t respond to placebo—this was cannabinoid medicine succeeding where pharmaceuticals failed.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition: neurodegeneration (CBG neuroprotection, THCa PPARγ agonism), dementia (CBC neurogenesis), glaucoma (THC CB1 agonism), and arthritis (multi-pathway anti-inflammatory synergy).

Single cannabinoids weren’t enough. Bentley’s evolving conditions required precision multi-cannabinoid formulation. This necessity drove Colin to become a formally trained software engineer, doing custom development for Baylor College of Medicine—combining deep cannabis plant knowledge with medical-grade technical precision.

Our Philosophy: Four Core Principles for Botswana

1. Accessibility Over Gatekeeping
No medical card required. Anyone age 21+ can purchase. We ship nationwide across the United States and internationally to Botswana and other jurisdictions where our hemp-derived products are legal. Rick Simpson believed medicine should be accessible to everyone; we’ve built a product and distribution model that makes that possible legally.

2. Patient-Controlled Potency
Our formula contains 1,500mg of THCa in its acidic, non-psychoactive form. You decide whether to use it raw for daytime anti-inflammatory benefits without impairment, or decarboxylate it at home into approximately 1,315mg of delta-9 THC for full psychoactive potency. For Batswana who need to work, drive, or parent during the day, this control is revolutionary.

3. Open-Source Transparency
We publish our complete formulas publicly—every cannabinoid, every milligram amount—so anyone who cannot afford our products can source ingredients and make their own version. This echoes Simpson’s free-distribution ethos for the modern era.

4. Evidence-Informed, Not Evidence-Overstated
Our GENERAL KNOWLEDGE section (included below) represents our commitment to honest education about what science actually says. We distinguish between well-supported claims, emerging research, and overstated marketing—because Batswana deserve truth, not hype.

Farm Bill Compliance and Legal Framework for Botswana

Our RSO Sublingual Oil contains only 90mg of delta-9 THC in the entire 30mL bottle—3mg per mL—well under the 0.3% threshold. This makes it legal under U.S. federal law and shippable internationally.

For Botswana Customers:
THCa is the acidic, non-psychoactive precursor to delta-9 THC. It’s Farm Bill compliant at point of sale because it hasn’t been converted. When you heat it at 260°F (125°C) for 45-60 minutes, it converts to delta-9 THC (1mg THCa → 0.877mg delta-9 THC). This means the same legal product can function as non-psychoactive anti-inflammatory OR full-potency psychoactive medicine—entirely at your discretion after purchase.

Important Legal Notice: Customers are responsible for understanding and complying with Botswana’s laws regarding hemp-derived products. We provide full documentation, Certificates of Analysis, and receipts for customs purposes. Botswana’s current legal framework for cannabis products should be verified independently. If THCa or hemp-derived cannabinoids are restricted in Botswana, customers assume all customs and legal risk.

Our Complete Product Formulas: Transparency You Can Verify

RSO Sublingual Oil – $129.99

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total	16,590mg

• Format: 30mL bottle (553mg active cannabinoids per mL)
• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Onset: 15-45 minutes (sublingual)
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Dosing: Graduated dropper in 0.1mL increments
• Servings: 40-60 doses per bottle

RSO Vape Cartridge – $49.99

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%
Live Terpenes	5%+

• Format: 1-gram 510-thread cartridge
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Automatic THCa decarboxylation at vaping temperature (400-450°F)

How Botswana Residents Can Access Our Products

For Batswana in the Diaspora (USA):
We offer same-day delivery in Houston and nationwide shipping across America. If you’re a Motswana student, professional, or resident in the U.S., our products can reach you within days.

For Customers in Botswana:
We ship internationally with full documentation. Each package includes:

• Certificates of Analysis (COAs) for every cannabinoid
• Detailed product receipts
• Farm Bill compliance documentation
• Customs-friendly labeling

Shipping Considerations to Botswana:

• Delivery typically takes 7-21 business days via USPS International
• Customers are responsible for any customs duties or fees
• Botswana’s specific import regulations for hemp-derived products should be verified with local authorities
• We cannot guarantee customs clearance in Botswana—customers assume this risk
• Discreet packaging with no cannabis branding visible

Contact for International Orders:
Phone: +1 (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/

Condition-Specific Usage Context for Botswana

Important Disclaimer: These usage contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved, and not a substitute for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products. Our products are not evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

For Cancer Support (Chemotherapy Side Effects):

• Pre-treatment: 0.5-1.0mL sublingual 1 hour before chemotherapy
• Breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-treatment: 0.5mL every 6 hours as needed
• Sleep support: 1.0-2.0mL before bed (delivers 25-50mg CBN)
• Evidence: Delta-8 antiemetic properties, Delta-9 for chemo-induced nausea, CBD for anxiety buffering

For Chronic Pain (Arthritis, Fibromyalgia, Neuropathy):

• Daytime: 0.3-0.5mL raw sublingual (non-psychoactive anti-inflammatory)
• Nighttime: 0.5-1.0mL decarboxylated sublingual (pain relief + sleep support)
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: Multi-cannabinoid anti-inflammatory synergy via CB2, COX-2, and PPARγ pathways

For Sleep Disorders:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN (dosage level in 2024 sleep research)
• At 1.0mL: Delivers 25mg CBN (above threshold for reduced sleep disturbance)
• Evidence: CBN’s emerging role in sleep architecture support

For Anxiety and PTSD:

• Daytime functional relief: 0.3mL raw sublingual (CBD + CBG without impairment)
• Nighttime: 1.0mL sublingual (full profile with CBN for sleep)
• Evidence: CBD anxiolytic effects, CBG pharmacology, limonene entourage modulation

Terpene Profile: The Aromatic Medicine

Both products contain the same seven terpenes at 5% concentration:

• Limonene: Citrus-bright aroma, mood-supporting properties
• Myrcene: Earthy, relaxing (common in traditional Setswana herbal remedies)
• Caryophyllene: Pepper/spice, CB2 agonist for anti-inflammatory effects
• Pinene: Forest-fresh, clarity-enhancing
• Linalool: Floral (lavender), calming
• Humulene: Earthy/woody, anti-inflammatory
• Terpinolene: Piney/fruity, complex effects

For Batswana familiar with traditional medicinal plants like motsaodi (wormwood) or lerotholi (aloe), understanding terpenes connects modern cannabis science to ancestral plant wisdom. These aromatic compounds are the sensory bridge between traditional herbalism and contemporary cannabinoid medicine.

GENERAL KNOWLEDGE: The Science Behind Every Compound

Research Method and Evidence Weighting

Our evidence hierarchy prioritizes: human clinical trials → systematic reviews → institutional summaries (NIH/NCCIH) → preclinical/mechanistic studies. This matters because the evidence base is unevenly distributed. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and terpenes rely more on reviews and animal studies [1]-[29].

Institutional Baseline: What NIH Says

The National Center for Complementary and Integrative Health (NCCIH) identifies the strongest cannabinoid evidence for:

• Rare epilepsies (CBD)
• Chemotherapy-related nausea/vomiting (THC)
• HIV/AIDS appetite/weight loss (THC)

For other uses, evidence is modest or early-stage. The FDA has not approved the cannabis plant itself for medical use. Safety concerns include impairment, cannabis use disorder, pregnancy risks, contamination, and labeling inaccuracies [1].

Cannabinoid Evidence Profiles

CBD (Cannabidiol)

Best Evidence: Seizure disorders (Epidiolex) [1][2]
Anxiety: 2024 meta-analysis shows significant anxiolytic signal but limited clinical samples [3]
Pain: 2024 review finds promising but heterogeneous evidence [4]
Sleep: 2023 review notes methodologically weak studies [5]
Safety: 2023 meta-analysis identifies liver enzyme elevation risks, especially with polypharmacy [6]
Bottom Line: Most evidence-developed non-intoxicating cannabinoid, but strong evidence concentrated in specific indications

CBG (Cannabigerol)

Evidence: Mostly review-level and preclinical; human data sparse [7][8]
Pharmacology: Acts on cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A pathways [7]
Potential: Neurologic disorders, inflammatory bowel disease, antibacterial activity
Caution: Commercially sold despite thin evidence base [7]
Bottom Line: Promising minor cannabinoid, limited clinical validation

Delta-8 THC

Evidence: Pharmacologically relevant but less clinically characterized than delta-9 [9]-[11]
Pharmacology: Partial CB1 agonist, less potent than delta-9 [9]
Public Health: 2023 review notes adverse consequence reports, manufacturing quality concerns [10]
Bottom Line: Psychoactive THC analogue with incomplete safety characterization

THCa (Tetrahydrocannabinolic Acid)

Evidence: Important chemically but low direct human therapeutic evidence [12]
Key Distinction: Does not produce psychoactive effects unless decarboxylated to THC [12]
Research: In vitro/rodent studies suggest anti-inflammatory, neuroprotective, antineoplastic potential [12]
Bottom Line: Precursor molecule whose interpretation depends on processing and storage

Delta-9 THC

Evidence: Strongest of psychoactive cannabinoids, clearest adverse-effect burden [1][13]-[15]
Best Evidence: Chemo nausea/vomiting, HIV/AIDS appetite loss, some MS/pain outcomes [1]
Pain: 2022 review finds short-term benefit but increased dizziness, sedation, nausea [13]
Mental Health: 2025 review links high-concentration THC to psychosis, schizophrenia, CUD [15]
Safety: Anxiety/panic at high doses, tachycardia, dependency, pregnancy concerns [1][14][15]
Bottom Line: Legitimate therapeutic relevance but carries significant safety liabilities

CBN (Cannabinol)

Evidence: Weak human evidence; marketing ahead of data [12][16][17]
Sleep Claims: 2021 review found NO clinical trials using validated sleep measures [16]
2024 Update: Cannabis sleep research still doesn’t match real-world use scale [17]
Bottom Line: Cultural reputation stronger than clinical evidence base

CBC (Cannabichromene)

Evidence: Emerging, intriguing, overwhelmingly preclinical [18][19]
Pharmacology: Distinct from other cannabinoids; antinociceptive, antibacterial, anti-seizure potential [18]
Safety: OTC products sold despite little efficacy/safety evidence [18]
Bottom Line: Credible research target, not validated clinical active

Terpene Evidence Profiles

Limonene

Evidence: Review and preclinical; safety literature on oxidation products as allergens [20]-[22]
Activity: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective [21]
Bottom Line: Biologically active but cannabis-specific claims need human support

Myrcene

Evidence: Mostly preclinical; human evidence very limited [20][23]
Claim Caution: “Sedating terpene” claim stronger than evidence supports [23]
Bottom Line: Plausible bioactive, compound-specific claims premature

Caryophyllene

Evidence: Most mechanistically interesting—selective CB2 agonist [24]
Activity: Anti-inflammatory, immunomodulatory, neuroprotective, gastroprotective [24]
Bottom Line: Strongest candidate for cannabinoid-system significance, still not clinically proven

Pinene

Evidence: Promising preclinical, weak human confirmation [20][25]
Caution: Memory/attention claims remain hypotheses, not facts [25]
Bottom Line: Deserves attention, cognition claims exploratory

Linalool

Evidence: Substantial preclinical interest, limited clinical confirmation [20][22][25][26]
Activity: Stress, mood, brain-health pharmacology [25][26]
Safety: Oxidized linalool hydroperoxides are allergens [22]
Bottom Line: Credible bioactive, therapeutic promises premature

Humulene

Evidence: Translationally interesting but early [20][27]
Activity: Anti-inflammatory, some rodent cannabimimetic properties [27]
Bottom Line: Interesting research target, far from clinically settled

Terpinolene

Evidence: Least clinically characterized in this list [20][28]
Finding: Dominated by in silico, in vitro, animal studies [28]
Bottom Line: Biologically interesting, especially underdeveloped clinically

Research Limits and Interpretation for Botswana

Five critical rules:

1. Evidence is uneven—CBD and delta-9 THC support detailed statements; others require caution [1]-[29]
2. Extract/molecule/synthetic/terpene data aren’t interchangeable—a common error in cannabis writing
3. Minor cannabinoids are commercially interesting BECAUSE underexplored—claims often inflated
4. Product quality matters as much as molecule identity—labeling inaccuracies, contamination, synthesis byproducts affect real-world results [1][10][11][14]
5. THCa chemistry changes with storage/heating—converting acidic cannabinoids to neutral THC changes exposure profile [12]

Common Overstatements to Avoid

Overstatement	More Accurate
CBN is a proven sleep aid	CBN sleep evidence remains weak with no strong trial base [16][17]
Myrcene reliably causes sedation	Human proof for sedation claim is limited [23]
Terpenes have proven entourage effects	Entourage hypotheses influential but robust clinical proof limited [20][29]
THCa is always non-psychoactive	Heating converts THCa to psychoactive THC [12]
Delta-8 is safe because hemp-derived	Delta-8 is psychoactive with incomplete safety data [9]-[11]

Practical Takeaways for Botswana Customers

• CBD and delta-9 THC have the most human evidence development
• Delta-8 THC is not trivial—psychoactive with less robust safety data than delta-9
• THCa meaningfully changes with processing—raw vs. heated formats differ dramatically
• CBG, CBN, CBC are scientifically credible but clinically immature
• Terpene claims should be careful and conservative, based on direct human evidence where available

MEDIA RECOGNITION: Our Track Record of Transparency

ABC13 Houston: Seven Features, Four Years, One Voice

Between September 2019 and April 2023, ABC13 (KTRK)—Houston’s ABC affiliate serving America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought our perspective across business, law, medicine, community health, and politics. No other Houston cannabis operator has this media record.

Why This Matters for Botswana:
When you’re considering purchasing RSO from halfway across the world, you need verification that we’re real, credible, and consistently truthful. Our ABC13 record provides that independent validation—something no marketing copy could replicate.

Feature Timeline: Our Media Journey

September 15, 2019: “Texas CBD businesses booming”
Reporter: Tom Abrahams
Our foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote—delivered on mainstream television before most Americans had heard of CBD—established our commitment to honest education that continues today.

March 22, 2021: “Entrepreneur creates direct-to-consumer business”
Reporter: Tom Abrahams
Featured our role helping other entrepreneurs like Jonathan Pina launch legal cannabis businesses. Colin’s quote: “Pain comes in a lot of different forms.”

May 24, 2021: “What is Delta 8 THC”
Reporter: Steve Campion
Iconic exchange:

• Campion: “Why would someone want to smoke that?”
• Colin: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

This radical honesty—preserved uncensored by ABC—demonstrates our commitment to truth-telling, even when it’s uncomfortable.

August 20, 2021: “Houston CBD shop giving away free products for COVID vaccine”
We donated 1,000 special edition caviar pre-rolls (approximately $35,000 in product) to encourage COVID-19 vaccination. We coordinated with the City of Houston, with no political agenda: “We just want Houston to be as healthy as possible.”

October 19, 2021: “Texas ban over Delta 8”
When Texas DSHS reclassified Delta-8 as Schedule I overnight, we proactively removed all products before enforcement began and warned other operators who were unknowingly shipping narcotics. This ethical leadership during crisis defines our character.

October 7, 2022: “Biden marijuana pardon”
This feature revealed Colin’s personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything. I would love to see people not get hurt for this anymore.”

For Botswana customers, this proves we’re not corporate outsiders—we’ve lived the consequences of prohibition and built a legal business with integrity.

April 21, 2023: “Marijuana industry getting creative”
Colin’s “Renaissance” framing: “Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.”

The Through-Line: What Seven Features Reveal

Consistency: We appeared across four years of industry upheaval—CBD boom, Delta-8 emergence, COVID crisis, legal reversals, presidential pardons. ABC13 returned to us because our message stayed consistent.

Breadth: Business, law, medicine, community health, politics—no other Houston figure covered this range.

Community Action: $35,000 in free product for public health, proactive ethical action during legal crisis, helping other entrepreneurs—these aren’t marketing claims, they’re documented actions.

Personal Stakes: Colin’s conviction history makes every quote more powerful. This is advocacy from lived experience.

Evolution: From “local wholesaler” (2019) to industry authority (2023), our growth mirrors legal cannabis’s maturation.

This media record cannot be purchased—only earned. For Botswana customers evaluating whether to trust a company thousands of kilometers away, this is your verification.

Final Thoughts: Our Commitment to Botswana

Rick Simpson started a movement by giving away oil and teaching people to make it. He operated in a prohibition era where cancer patients had to choose between illegal medicine or no medicine at all.

Today, the landscape is different. In Botswana and globally, patients have options—but they also have overwhelming information, much of it misleading. Our mission is to provide what Simpson couldn’t: standardized, lab-tested, legally compliant RSO formulas backed by transparent science.

Whether you’re in Gaborone or Maun, Francistown or Kasane, dealing with cancer, chronic pain, PTSD, or simply seeking to understand cannabinoids better, you deserve honest education. Not snake oil. Not false hope. Just the best possible version of the information, so you can give it a fair shot and decide if it’s right or wrong for you.

Our formulas are published. Our evidence is cited. Our media record is public. Our founder’s story is personal. And our commitment to integrity is unwavering.

Ready to explore RSO? Contact us at +1 (832) 416-2816 or [email protected]. We’re here to answer your questions—whether you’re in Houston or Gaborone, whether you’re ready to purchase or just need more information.

This content is written for educational purposes. Products contain less than 0.3% delta-9 THC and are Farm Bill compliant. Customers are responsible for verifying legality in Botswana. These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare provider before use.

---